Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of C. elegans
Malabika Maulik, Swarup Mitra, Ajiel Mae Basmayor, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 19

Showing 19 citing articles:

Exploring Caenorhabditis elegans as Parkinson’s Disease Model: Neurotoxins and Genetic Implications
Larissa Pereira Dantas da Silva, Érika da Cruz Guedes, Isabel Cristina Oliveira Fernandes, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 6
Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson’s disease
Fahim Muhammad, Yan Liu, Ningbo Wang, et al.
NeuroToxicology (2022) Vol. 93, pp. 128-139
Closed Access | Times Cited: 26
Anti-Parkinson Effects of Holothuria leucospilota-Derived Palmitic Acid in Caenorhabditis elegans Model of Parkinson’s Disease
Tanatcha Sanguanphun, Sukrit Promtang, Nilubon Sornkaew, et al.
Marine Drugs (2023) Vol. 21, Iss. 3, pp. 141-141
Open Access | Times Cited: 13
Rotenone neurotoxicity: Relevance to Parkinson's disease
Vivek Lawana, Jason R. Cannon
Advances in neurotoxicology (2020), pp. 209-254
Closed Access | Times Cited: 37
Vesicle trafficking and lipid metabolism in synucleinopathy
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
Acta Neuropathologica (2020) Vol. 141, Iss. 4, pp. 491-510
Open Access | Times Cited: 35
Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
Daniel F. Tardiff, Matthew C. Lucas, Iwona Wrona, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 4, pp. 2171-2189
Open Access | Times Cited: 22
Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation
Elena Caldero-Escudero, Silvia Romero-Sanz, Sergio de la Fuente
Methods in cell biology (2024), pp. 1-34
Closed Access | Times Cited: 3
Preventive treatments to slow substantia nigra damage and Parkinson’s disease progression: A critical perspective review
Geir Bjørklund, Maryam Dadar, George Anderson, et al.
Pharmacological Research (2020) Vol. 161, pp. 105065-105065
Closed Access | Times Cited: 27
Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy
Saranna Fanning, Haley Cirka, Jennifer L. Thies, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 13
A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
Silke Nuber, Chee Yeun Chung, Daniel F. Tardiff, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 1018-1036
Open Access | Times Cited: 12
Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans model
Inam Ullah, Longhe Zhao, Shahab Uddin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Simple model systems reveal conserved mechanisms of Alzheimer’s disease and related tauopathies
Yuwei Jiang, Lesley T. MacNeil
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
SCD Inhibition Protects from α-Synuclein-Induced Neurotoxicity But Is Toxic to Early Neuron Cultures
Justin W. Nicholatos, Joost Groot, Shekhar Dhokai, et al.
eNeuro (2021) Vol. 8, Iss. 4, pp. ENEURO.0166-21.2021
Open Access | Times Cited: 13
Swertiamarin from Enicostemma littorale, counteracts PD associated neurotoxicity via enhancement α-synuclein suppressive genes and SKN-1/NRF-2 activation through MAPK pathway
Taruna Pandey, Aparna Shukla, Mashu Trivedi, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104655-104655
Closed Access | Times Cited: 12
Transcriptional analysis of the response of C. elegans to ethanol exposure
Mark G. Sterken, Marijke H. van Wijk, Elizabeth C. Quamme, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Sporadic SNCA mutations A18T and A29S exhibit variable effects on protein aggregation, cell viability and oxidative stress
Neha Joshi, Tanveera Rounaque Sarhadi, Atchaya Raveendran, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 5547-5556
Closed Access | Times Cited: 4
Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
Tae‐Eun Kim, Andrew J. Newman, Thibaut Imberdis, et al.
Human Molecular Genetics (2021) Vol. 30, Iss. 23, pp. 2332-2346
Open Access | Times Cited: 9
Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay
Teresa Rubio‐Tomás, Nektarios Tavernarakis
Biogerontology (2022) Vol. 23, Iss. 5, pp. 541-557
Closed Access | Times Cited: 5
The Mitochondrial Na+/Ca2+ Exchanger Inhibitor CGP37157 Preserves Muscle Structure and Function to Increase Lifespan and Healthspan in Caenorhabditis elegans
Paloma García-Casas, Pilar Álvarez-Illera, Eva Gómez‐Orte, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Page 1

Scroll to top